InfuSystem (NYSE:INFU) Trading Up 2.6% - Here's What Happened

InfuSystem Holdings, Inc. (NYSE:INFU - Get Free Report) was up 2.6% during mid-day trading on Wednesday . The company traded as high as $6.30 and last traded at $6.29. Approximately 70,000 shares were traded during trading, a decline of 40% from the average daily volume of 116,204 shares. The stock had previously closed at $6.13.

Wall Street Analyst Weigh In

A number of research analysts have recently issued reports on INFU shares. B. Riley upgraded shares of InfuSystem to a "strong-buy" rating in a report on Thursday, May 8th. Wall Street Zen cut shares of InfuSystem from a "strong-buy" rating to a "buy" rating in a report on Wednesday, May 14th. Finally, Sidoti upgraded shares of InfuSystem to a "strong-buy" rating in a report on Tuesday, March 18th.

InfuSystem Trading Down 1.6%

The firm has a market capitalization of $130.09 million, a PE ratio of 103.18 and a beta of 1.81. The firm's fifty day moving average is $5.86 and its two-hundred day moving average is $6.49. The company has a debt-to-equity ratio of 0.50, a current ratio of 1.98 and a quick ratio of 1.59.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the company. BNP Paribas Financial Markets boosted its stake in InfuSystem by 67.9% in the fourth quarter. BNP Paribas Financial Markets now owns 6,844 shares of the company's stock valued at $58,000 after acquiring an additional 2,768 shares during the last quarter. Jump Financial LLC purchased a new position in InfuSystem in the first quarter valued at about $58,000. Wells Fargo & Company MN boosted its stake in InfuSystem by 51.7% in the fourth quarter. Wells Fargo & Company MN now owns 9,286 shares of the company's stock valued at $78,000 after acquiring an additional 3,165 shares during the last quarter. Summit Global Investments purchased a new position in InfuSystem in the fourth quarter valued at about $86,000. Finally, Virtu Financial LLC purchased a new position in InfuSystem in the first quarter valued at about $86,000. 71.13% of the stock is currently owned by hedge funds and other institutional investors.

InfuSystem Company Profile

InfuSystem Holdings, Inc, through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Patient Services and Device Solutions. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states.